Differential Modification of p27^Kip1 Controls Its Cyclin D-cdk4 Inhibitory Activity

REFERENCES

• Adams, P. D., X. Li, W. R. Sellers, K. B. Baker, X. Leng, J. W. Harper, Y. Taya, and W. G. Kaelin, Jr. 1999. Retinoblastoma protein contains a C-terminal motif that targets it for phosphorylation by cyclin-cdk complexes. Mol. Cell. Biol. 19:1068–1080.
   PubMed Web of Science ®Google Scholar
• Adams, P. D., W. R. Sellers, S. K. Sharma, A. D. Wu, C. M. Nalin, and W. G. Kaelin, Jr. 1996. Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors. Mol. Cell. Biol. 16:6623–6633.
   PubMed Web of Science ®Google Scholar
• Alkarain, A., R. Jordan, and J. Slingerland. 2004. p27 deregulation in breast cancer: prognostic significance and implications for therapy. J. Mammary Gland Biol. Neoplasia 9:67–80.
   PubMedGoogle Scholar
• Alt, J. R., A. B. Gladden, and J. A. Diehl. 2002. p21(Cip1) promotes cyclin D1 nuclear accumulation via direct inhibition of nuclear export. J. Biol. Chem. 277:8517–8523.
   PubMed Web of Science ®Google Scholar
• Bagui, T. K., S. Mohapatra, E. Haura, and W. J. Pledger. 2003. p27Kip1 and p21Cip1 are not required for the formation of active cyclin D-cdk4 complexes. Mol. Biol. Cell 23:7285–7290.
   Google Scholar
• Baughn, L. B., M. Di Liberto, K. Wu, P. L. Toogood, T. Louie, R. Gottschalk, R. Niesvizky, H. Cho, S. Ely, M. A. Moore, and S. Chen-Kiang. 2006. A novel orally active small molecule potently induces G1 arrest in primary myeloma cells and prevents tumor growth by specific inhibition of cyclin-dependent kinase 4/6. Cancer Res. 66:7661–7667.
   PubMed Web of Science ®Google Scholar
• Birge, R. B., B. S. Knudsen, D. Besser, and H. Hanafusa. 1996. SH2 and SH3-containing adaptor proteins: redundant or independent mediators of intracellular signal transduction. Genes Cells 1:595–613.
   PubMedGoogle Scholar
• Blain, S. W., E. Montalvo, and J. Massagué. 1997. Differential interaction of the cyclin-dependent kinase (cdk) inhibitor p27 with cyclin A-cdk2 and cyclin D2-cdk4. J. Biol. Chem. 272:25863–25872.
   PubMed Web of Science ®Google Scholar
• Blain, S. W., H. I. Scher, C. Cordon-Cardo, and A. Koff. 2003. p27 as a target for cancer therapeutics. Cancer Cell 3:111–115.
   PubMed Web of Science ®Google Scholar
• Boggon, T. J., and M. J. Eck. 2004. Structure and regulation of Src family kinases. Oncogene 23:7918–7927.
   PubMed Web of Science ®Google Scholar
• Castano, E., Y. Kleyner, and B. D. Dynlacht. 1998. Dual cyclin-binding domains are required for p107 to function as a kinase inhibitor. Mol. Cell. Biol. 18:5380–5391.
   PubMedGoogle Scholar
• Chen, J., P. Saha, S. Kornbluth, B. D. Dynlacht, and A. Dutta. 1996. Cyclin-binding motifs are essential for the function of p21Cip1. Mol. Cell. Biol. 16:4673–4682.
   PubMed Web of Science ®Google Scholar
• Cheng, M., P. Olivier, J. A. Diehl, M. Fero, M. F. Roussel, J. M. Roberts, and C. J. Sherr. 1999. The p21(Cip1) and p27(Kip1) CDK ‘inhibitors’ are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18:1571–1583.
   PubMed Web of Science ®Google Scholar
• Cheng, M., V. Sexl, C. J. Sherr, and M. Roussel. 1998. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proc. Natl. Acad. Sci. USA 95:1091–1096.
   PubMed Web of Science ®Google Scholar
• Chu, I., J. Sun, A. Arnaout, H. Kahn, W. Hanna, S. Narod, P. Sun, C. K. Tan, L. Hengst, and J. Slingerland. 2007. p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2. Cell 128:281–294.
   PubMed Web of Science ®Google Scholar
• Dyson, N. 1998. The regulation of E2F by pRb-family proteins. Genes Dev. 12:2245–2262.
   PubMed Web of Science ®Google Scholar
• Gao, H., X. Ouyang, W. Banach-Petrosky, A. D. Borowsky, Y. Lin, M. Kim, H. Lee, W. J. Shih, R. D. Cardiff, M. M. Shen, and C. Abate-Shen. 2004. A critical role for p27kip1 gene dosage in a mouse model of prostate carcinogenesis. Proc. Natl. Acad. Sci. USA 101:17204–17209.
   PubMed Web of Science ®Google Scholar
• Gossen, M., and H. Bujard. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89:5547–5551.
   PubMed Web of Science ®Google Scholar
• Grimmler, M., Y. Wang, T. Mund, Z. Cilensek, E. M. Keidel, M. B. Waddell, H. Jakel, M. Kullmann, R. W. Kriwacki, and L. Hengst. 2007. Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases. Cell 128:269–280.
   PubMed Web of Science ®Google Scholar
• Hashimoto, Y., K. Kohri, Y. Kaneko, H. Morisaki, T. Kato, K. Ikeda, and M. Nakanishi. 1998. Critical role for the 3-10 helix region of p57(Kip2) in cyclin-dependent kinase 2 inhibition and growth suppression. J. Biol. Chem. 273:16544–16550.
   PubMedGoogle Scholar
• Jirawatnotai, S., D. S. Moons, C. O. Stocco, R. Franks, D. B. Hales, G. Gibori, and H. Kiyokawa. 2003. The CDK inhibitors p27Kip1 and p21Cip1 cooperate to restrict proliferative life span in differentiating ovarian cells. J. Biol. Chem. 278:17021–17027.
   PubMedGoogle Scholar
• Kardinal, C., M. Dangers, A. Kardinal, A. Koch, D. T. Brandt, T. Tamura, and K. Welte. 2006. Tyrosine phosphorylation modulates binding preference to a cyclin-dependent kinase and subcellular localization of p27kip1 in the acute promyelocytic leukemia cell line NB4. Blood 107:1133–1140.
   PubMedGoogle Scholar
• Kato, A., H. Takahashi, Y. Takahashi, and H. Matsushime. 1997. Inactivation of the cyclin D-dependent kinase in the rat fibroblast cell line, 3Y1, induced by contact inhibition. J. Biol. Chem. 272:8065–8070.
   PubMedGoogle Scholar
• Kato, J.-Y., M. Matsuoka, D. K. Strom, and C. J. Sherr. 1994. Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase. Mol. Cell. Biol. 14:2713–2721.
   PubMed Web of Science ®Google Scholar
• Koff, A., M. Ohtsuki, K. Polyak, J. M. Roberts, and J. Massagué. 1993. Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-β. Science 260:536–539.
   PubMed Web of Science ®Google Scholar
• Kwon, Y. H., A. Jovanovic, M. S. Serfas, H. Kiyokawa, and A. L. Tyner. 2002. p21 functions to maintain quiescence of p27-deficient hepatocytes. J. Biol. Chem. 277:41417–41422.
   PubMedGoogle Scholar
• LaBaer, J., M. D. Garrett, L. F. Stevenson, J. M. Slingerland, C. Sandhu, H. S. Chou, A. Fattaey, and E. Harlow. 1997. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11:847–862.
   PubMed Web of Science ®Google Scholar
• Landis, W. M., S. B. Pawlyk, T. Li, P. Sicinski, and W. P. Hinds. 2006. Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis. Cancer Cell 9:13–22.
   PubMed Web of Science ®Google Scholar
• Mahony, D., D. A. Parrry, and E. Lees. 1998. Active cdk6 complexes are predominantly nuclear and represent only a minority of the cdk6 in T cells. Oncogene 16:603–611.
   PubMed Web of Science ®Google Scholar
• Malumbres, M., and M. Barbacid. 2001. To cycle or not to cycle: a critical decision in cancer. Nat. Rev. Cancer 1:222–231.
   PubMed Web of Science ®Google Scholar
• Massagué, J., S. W. Blain, and R. S. Lo. 2000. TGF-β signaling in growth control, cancer and heritable disease. Cell 103:295–309.
   PubMed Web of Science ®Google Scholar
• McConnell, B. B., F. J. Gregory, F. J. Stott, E. Hara, and G. Peters. 1999. Induced expression of p16Ink4a inhibits both cdk4- and cdk2-associated kinase activity by reassortment of cyclin-cdk inhibitor complexes. Mol. Cell. Biol. 19:1981–1989.
   PubMed Web of Science ®Google Scholar
• Muraoka, R. S., A. E. G. Lenferink, B. Law, E. Hamilton, D. M. Brantley, L. R. Roebuck, and C. L. Arteaga. 2002. Erb2/Neu-induced cyclin D1-dependent transformation is accelerated in p27-haploinsufficient mammary epithelial cells but impaired in p27-null cells. Mol. Cell. Biol. 22:2204–2219.
   PubMed Web of Science ®Google Scholar
• Nickeleit, I., S. Zender, U. Kossatz, and N. P. Malek. 2007. p27kip1: a target for tumor therapies? Cell Div. 2:13.
   PubMedGoogle Scholar
• Nourse, J., E. Firpo, M. W. Flanagan, M. Meyerson, K. Polyak, M. H. Lee, J. Massagué, G. R. Crabtree, and J. M. Roberts. 1994. Rapamycin prevents IL-2-mediated elimination of the cyclin-CDK kinase inhibitor, p27Kip1. Nature 372:570–573.
   PubMed Web of Science ®Google Scholar
• Obaya, A. J., I. Kotenko, M. D. Cole, and J. M. Sedivy. 2002. The proto-oncogene c-myc acts through the cyclin-dependent kinase (Cdk) inhibitor p27kip1 to facilitate the activation of Cdk4/6 and early G1 phase progression. J. Biol. Chem. 277:31263–31269.
   PubMed Web of Science ®Google Scholar
• Ortega, S., M. Malumbres, and M. Barbacid. 2002. Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim. Biophys. Acta 1602:73–87.
   PubMed Web of Science ®Google Scholar
• Parry, D., D. Mahony, K. Wills, and E. Lees. 1999. Cyclin D-cdk subunit arrangement is dependent on the availability of competing Ink4 and p21 class inhibitors. Mol. Cell. Biol. 19:1775–1783.
   PubMed Web of Science ®Google Scholar
• Pavletich, N. P. 1999. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. J. Mol. Biol. 287:821–828.
   PubMed Web of Science ®Google Scholar
• Polyak, K., M. H. Lee, H. Erdjument-Bromage, A. Koff, J. M. Roberts, P. Tempst, and J. Massagué. 1994. Cloning of p27kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59–66.
   PubMed Web of Science ®Google Scholar
• Poon, R. Y. C., H. Toyoshima, and T. Hunter. 1995. Redistribution of the CDK inhibitor p27 between different cyclin-CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation. Mol. Biol. Cell 6:1197–1213.
   PubMed Web of Science ®Google Scholar
• Reynisdóttir, I., and J. Massagué. 1997. The subcellular location of p15Ink4b and p27Kip1 coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev. 11:492–503.
   PubMed Web of Science ®Google Scholar
• Reynisdóttir, I., K. Polyak, A. Iavarone, and J. Massagué. 1995. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev. 9:1831–1845.
   PubMed Web of Science ®Google Scholar
• Russo, A. A., P. D. Jeffrey, A. Patten, J. Massagué, and N. Pavletich. 1996. Crystal structure of the p27Kip1 cyclin-dependent kinase inhibitor bound to the cyclin A-cdk2 complex. Nature 382:325–331.
   PubMed Web of Science ®Google Scholar
• Russo, A. A., P. D. Jeffrey, and N. Pavletich. 1996. Structural basis of cyclin-dependent kinase activation by phosphorylation. Nat. Struct. Biol. 3:696–700.
   PubMedGoogle Scholar
• Russo, A. A., L. Tong, J. O. Lee, P. D. Jeffrey, and N. Pavletich. 1998. Structural basis for inhibition of the cyclin-dependent kinase cdk6 by the tumour suppressor p16Ink4a. Nature 395:237–243.
   PubMed Web of Science ®Google Scholar
• Sandhu, C., J. Garbe, N. Bhattacharya, J. Daksis, C.-H. Pan, P. Yaswen, J. Koh, J. M. Slingerland, and M. R. Stampfer. 1997. Transforming growth factor β stabilizes p15Ink4B protein, increases p15Ink4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells. Mol. Cell. Biol. 17:2458–2467.
   PubMedGoogle Scholar
• Shapiro, G. I. 2006. Cyclin-dependent kinase pathways as targets for cancer treatment. J. Clin. Oncol. 24:1770–1783.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J., and J. M. Roberts. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13:1501–1512.
   PubMed Web of Science ®Google Scholar
• Slingerland, J. M., L. Hengst, C. Pan, D. Alexander, M. Stampfer, and S. I. Reed. 1994. A novel inhibitor of cyclin-cdk activity detected in transforming growth factor β-arrested epithelial cells. Mol. Cell. Biol. 14:3683–3694.
   PubMed Web of Science ®Google Scholar
• Soos, T. J., H. Kiyokawa, J. S. Yan, M. S. Rubin, A. Giordano, A. DeBlasio, S. Bottega, B. Wong, J. Mendelsohn, and A. Koff. 1996. Formation of p27-CDK complexes during the human mitotic cell cycle. Cell Growth Differ. 7:135–146.
   PubMedGoogle Scholar
• Stepanova, L., X. Leng, S. G. Parker, and J. W. Harper. 1996. Mammalian p50cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes cdk4. Genes Dev. 10:1491–1502.
   PubMed Web of Science ®Google Scholar
• Toyoshima, H., and T. Hunter. 1994. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78:67–74.
   PubMed Web of Science ®Google Scholar
• Trimarchi, J. M., and J. A. Lees. 2002. Sibling rivalry in the E2F family. Nat. Rev. Mol. Cell Biol. 3:11–20.
   PubMed Web of Science ®Google Scholar
• Tsutsui, T., B. Hesabi, D. S. Moons, P. P. Pandolfi, K. S. Hansel, A. Koff, and H. Kiyokawa. 1999. Targeted disruption of cdk4 delays cell cycle entry with enhanced p27kip1 activity. Mol. Cell. Biol. 19:7011–7019.
   PubMed Web of Science ®Google Scholar
• Vlach, J., S. Hennecke, K. Alevizopoulos, D. Conti, and B. Amati. 1996. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc. EMBO J. 15:6595–6604.
   PubMed Web of Science ®Google Scholar
• Warner, B. J., S. W. Blain, J. Seoane, and J. Massagué. 1999. Myc downregulation by transforming growth factor β required for activation of the p15Ink4b G1 arrest pathway. Mol. Cell. Biol. 19:5913–5922.
   PubMed Web of Science ®Google Scholar
• Wu, J. J., D. E. Afar, H. Phan, O. N. Witte, and K. S. Lam. 2002. Recognition of multiple substrate motifs by the c-ABL protein tyrosine kinase. Comb. Chem. High Throughput Screen. 5:83–91.
   PubMedGoogle Scholar
• Yu, Q., E. Sicinska, Y. Geng, M. Ahnstrom, A. Zagozdzon, Y. Kong, H. Gardner, H. Kiyokawa, N. L. Harris, O. Stal, and P. Sicinski. 2006. Requirement for CDK4 kinase function in breast cancer. Cancer Cell 9:23–32.
   PubMed Web of Science ®Google Scholar
• Zhu, X., M. Ohtsubo, R. M. Bohmer, J. M. Roberts, and R. K. Assoian. 1996. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and the phosphorylation of the retinoblastoma protein. J. Cell Biol. 133:391–403.
   PubMed Web of Science ®Google Scholar